Experts are meeting this week to discuss survivor care, keeping clinical samples, and setting research priorities.
A trial to see if a lower dose of one of the leading Ebola vaccine candidates can reduce reactions such as arthritis and skin rashes found that the effects persisted and that decreasing the dose had a negative impact on immune response. An international research team based in Switzerland published their findings on the lower VSV-EBOV dose yesterday in an early online edition of Lancet Infectious Diseases.
The vaccine was 100% effective in those who received it soon after possible exposure, setting the scene for it quickly to become a useful response tool.
The WHO announces a unified program for health emergencies, vaccine support, and other reforms.
A Salmonella outbreak linked to stuffed, raw chicken entrees that might appear to be cooked has grown to nine cases, as new individual cases in Minnesota and Illinois push the number of affected states to four, the Centers for Disease Control and Prevention (CDC) said in an update yesterday.
The agency reported seven outbreak cases on Jul 16.
With only 7 new cases, the countries recorded their lowest Ebola levels in more than a year.
Researchers found that the World Health Organization (WHO) Ebola case definition has a specificity of only 31.5%, and they noted that 9% of Ebola patients reported neither a fever nor any Ebola risk exposure, calling into question WHO norms, according to a large study yesterday in The Lancet Infectious Diseases.
Middle East respiratory syndrome coronavirus (MERS-CoV) has sickened four more people in Saudi Arabia in the past 2 days, one of them fatally, according to reports from the country's Ministry of Health (MOH).
With 26 new cases, much activity is centered in the two capitals for the 2nd week in a row.
The contract is for bolstering monoclonal antibody treatment for Ebola.
